Vicore Pharma Holding AB - ESG Rating & Company Profile powered by AI
Detailed ESG assessment of Vicore Pharma Holding AB are accessed by registering for free. This page contains a free Environmental, Social and Governance analysis covering Vicore Pharma Holding AB. The report of Vicore Pharma Holding AB was assembled by All Street Sevva using proprietary Cognitive Robots.
Vicore Pharma Holding AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.8; made up of an environmental score of 8.0, social score of 6.4 and governance score of 6.0.
6.8
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 294 | SMS Pharmaceuticals Ltd | 6.9 | High |
| 294 | Takeda Pharmaceutical Co Ltd | 6.9 | High |
| 314 | Vicore Pharma Holding AB | 6.8 | High |
| 314 | Camurus AB | 6.8 | High |
| 314 | Cassiopea SpA | 6.8 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Vicore Pharma Holding AB have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Vicore Pharma Holding AB disclose current and historical energy intensity?
Sign up for free to unlockDoes Vicore Pharma Holding AB report the average age of the workforce?
Sign up for free to unlockDoes Vicore Pharma Holding AB reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Vicore Pharma Holding AB disclose its ethnicity pay gap?
Sign up for free to unlockDoes Vicore Pharma Holding AB disclose cybersecurity risks?
Sign up for free to unlockDoes Vicore Pharma Holding AB offer flexible work?
Sign up for free to unlockDoes Vicore Pharma Holding AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Vicore Pharma Holding AB disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Vicore Pharma Holding AB conduct supply chain audits?
Sign up for free to unlockDoes Vicore Pharma Holding AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Vicore Pharma Holding AB conduct 360 degree staff reviews?
Sign up for free to unlockDoes Vicore Pharma Holding AB disclose the individual responsible for D&I?
Sign up for free to unlockDoes Vicore Pharma Holding AB disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Vicore Pharma Holding AB disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Vicore Pharma Holding AB disclose water use targets?
Sign up for free to unlockDoes Vicore Pharma Holding AB have careers partnerships with academic institutions?
Sign up for free to unlockDid Vicore Pharma Holding AB have a product recall in the last two years?
Sign up for free to unlockDoes Vicore Pharma Holding AB disclose incidents of discrimination?
Sign up for free to unlockDoes Vicore Pharma Holding AB allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Vicore Pharma Holding AB issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Vicore Pharma Holding AB disclose parental leave metrics?
Sign up for free to unlockDoes Vicore Pharma Holding AB disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Vicore Pharma Holding AB disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Vicore Pharma Holding AB disclose the pay ratio of women to men?
Sign up for free to unlockDoes Vicore Pharma Holding AB support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Vicore Pharma Holding AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Vicore Pharma Holding AB reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Vicore Pharma Holding AB involved in embryonic stem cell research?
Sign up for free to unlockDoes Vicore Pharma Holding AB disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Vicore Pharma Holding AB disclose its waste policy?
Sign up for free to unlockDoes Vicore Pharma Holding AB report according to TCFD requirements?
Sign up for free to unlockDoes Vicore Pharma Holding AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Vicore Pharma Holding AB disclose energy use targets?
Sign up for free to unlockDoes Vicore Pharma Holding AB disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Vicore Pharma Holding AB have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Vicore Pharma Holding AB
These potential risks are based on the size, segment and geographies of the company.
Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases. The company is developing VP01, a small molecule compound for oral administration that is in phase II clinical trial for the treatment of interstitial lung diseases, idiopathic pulmonary fibrosis (IPF), systemic sclerosis, and COVID-19; and VP02, a formulation and delivery route for an existing immunomodulatory compound, which is preclinical trials to treat patients with IPF. It has a cooperation and development agreement with Emeriti Bio AB; license agreement with Nanologica AB (publ); and a collaboration agreement with Alex Therapeutics AB for the development and clinical validation of a digital therapeutic (DTx) built on the Alex DTx platform. The company was formerly known as Mintage Scientific AB. Vicore Pharma Holding AB (publ) was founded in 2000 and is headquartered in Gothenburg, Sweden.